StrataGraft® Skin Tissue Expanded Access at Specific Study Sites ( StrataCAT )

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

January 26, 2022

Study Completion Date

January 26, 2022

Conditions
Deep Partial-thickness Burn
Interventions
BIOLOGICAL

StrataGraft skin tissue

StrataGraft skin tissue was delivered as a single topical application to no more than 3 separate burn sites, totaling up to approximately 2000 cm\^2 of treatment area using no more than 20 tissues.

Trial Locations (10)

15219

University of Pittsburgh Medical Center, Pittsburgh

20010

MedStar Health Research Institute, Washington D.C.

27157

Wake Forest University, Winston-Salem

32610

University of Florida (Health Shands Burn Center), Gainesville

33136

University of Missouri, Columbia

52242

University of Iowa, Iowa City

53792

University of Wisconsin Hospital, Madison

70113

University Medical Center New Orleans, New Orleans

70809

Baton Rouge General, Baton Rouge

92868-3298

University of California Irvine, Orange

All Listed Sponsors
lead

Stratatech, a Mallinckrodt Company

INDUSTRY

NCT04123548 - StrataGraft® Skin Tissue Expanded Access at Specific Study Sites ( StrataCAT ) | Biotech Hunter | Biotech Hunter